Is There Too Much Variability in Hyperkalemia Management?
Photo by Robina Weermeijer on Unsplash

Is There Too Much Variability in Hyperkalemia Management?

  The virtually-held National Kidney Foundation 2020 Spring Clinical Meetings explored various topics relating to nephrological conditions, treatment, and patient outcomes. One presentation, spearheaded by Dr. Adam Weinstein, MD, and…

Continue Reading Is There Too Much Variability in Hyperkalemia Management?
Scientists Explore the Epigenetic Causes of PAH
Photo by Robina Weermeijer on Unsplash

Scientists Explore the Epigenetic Causes of PAH

  Recently, researchers from European Molecular Biology Laboratory (EMBL) looked to understand the cause of pulmonary arterial hypertension (PAH). They collaborated with Stanford University through the Life Sciences Alliance. Because…

Continue Reading Scientists Explore the Epigenetic Causes of PAH
Doctors in Japan Transplant Stem Cells in Six-Day Old Newborn to Treat Urea Cycle Disorder
source: pixabay.com

Doctors in Japan Transplant Stem Cells in Six-Day Old Newborn to Treat Urea Cycle Disorder

  In an article in Medical Xpress, Japanese doctors have performed a “first” by transplanting liver cells (made with embryonic stem cells) into a newborn. The six-day-old infant was diagnosed with…

Continue Reading Doctors in Japan Transplant Stem Cells in Six-Day Old Newborn to Treat Urea Cycle Disorder
Fabry Disease: A Biologics License Application for Pegunigalsidase Alfa has Been Submitted to the FDA
source: pixabay.com

Fabry Disease: A Biologics License Application for Pegunigalsidase Alfa has Been Submitted to the FDA

According to a story from prnewswire.com, the Chiesi Global Rare Diseases and the biopharmaceutical company ProTalix Biotherapeutics have recently announced that they have submitted a Biologics License Application (BLA) for…

Continue Reading Fabry Disease: A Biologics License Application for Pegunigalsidase Alfa has Been Submitted to the FDA

An App in New Zealand Allows IBD Patients to Communicate with Their Specialists Virtually

IBDsmart Researchers at the University of Otago, led by Michael Shultz, have developed a new app called IBDsmart to help patients with ulcerative colitis or Crohn's disease receive care remotely.…

Continue Reading An App in New Zealand Allows IBD Patients to Communicate with Their Specialists Virtually
Study Identifies Bronchiectasis Risk Factors in Aspirin-Exacerbated Respiratory Disease
source: pixabay.com

Study Identifies Bronchiectasis Risk Factors in Aspirin-Exacerbated Respiratory Disease

According to a story from Pulmonology Advisor, a recent study has evaluated risk factors for the appearance of bronchiectasis in patients with aspirin-exacerbated respiratory disease (AERD). A small number of…

Continue Reading Study Identifies Bronchiectasis Risk Factors in Aspirin-Exacerbated Respiratory Disease